COVID-19 Vaccine for Children
FDA and CDC benefit-risk assessments raise questions
9 min readNov 2, 2021
On October 26th, the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the FDA approved one third dose of Pfizer’s COVID-19 vaccine for emergency use in children five to 11. On November 2nd, the CDC’s Advisory Committee on Immunization Practices (ACIP) unanimously approved the vaccine. Children could…
